Document Detail

Exposure to rizatriptan during pregnancy: post-marketing experience up to 30 June 2004.
MedLine Citation:
PMID:  16109049     Owner:  NLM     Status:  MEDLINE    
Merck & Co., Inc. evaluates outcomes of the use of rizatriptan during pregnancy through a Pregnancy Registry in the United States (US) and spontaneous reports for pregnancies reported from sources outside the US. Review of the outcomes of 25 prospective pregnancy reports in the Pregnancy Registry and reports from other sources does not suggest that treatment with rizatriptan predisposes patients to spontaneous abortions or congenital anomalies. However, the number of reports is small. Healthcare providers in the United States are encouraged to report any prenatal exposure to rizatriptan by calling the Pregnancy Registry at +1 (800) 986 8999 or visiting the Registry's website at
M Fiore; K E Shields; N Santanello; M R Goldberg
Related Documents :
18342289 - A case of recurrent hyperreactio luteinalis.
19083009 - Imatinib use during pregnancy and breast feeding: a case report and review of the liter...
2249209 - True hermaphrodite with bilateral ovotestes, bilateral gonadoblastomas and dysgerminoma...
20818969 - Coronary stenting after myocardial infarction during twin pregnancy--a case report.
18208949 - Trastuzumab treatment for breast cancer during pregnancy.
19561889 - Spontaneous pneumothorax: an unusual complication of pregnancy--a case report and revie...
3191059 - Pregnancy complicated by maternal heart disease. a review of 519 women.
2040229 - Khat-chewing during pregnancy-effect upon the off-spring and some characteristics of th...
20492379 - Difference of fetal heart rate accelerations based on 10 and 15 beats per minute.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cephalalgia : an international journal of headache     Volume:  25     ISSN:  0333-1024     ISO Abbreviation:  Cephalalgia     Publication Date:  2005 Sep 
Date Detail:
Created Date:  2005-08-19     Completed Date:  2005-10-12     Revised Date:  2008-02-11    
Medline Journal Info:
Nlm Unique ID:  8200710     Medline TA:  Cephalalgia     Country:  England    
Other Details:
Languages:  eng     Pagination:  685-8     Citation Subset:  IM    
Clinical Risk Management and Safety Surveillance, Merck Research Laboratories, West Point 19486, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abnormalities, Drug-Induced / epidemiology*
Pregnancy Outcome / epidemiology*
Serotonin Agonists / adverse effects*
Triazoles / adverse effects*
Reg. No./Substance:
0/Serotonin Agonists; 0/Triazoles; 0/Tryptamines; 145202-66-0/rizatriptan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Parasuicide, self-harm and suicide in Aboriginal people in rural Australia: a review of the literatu...
Next Document:  Facial pain in a neurological tertiary care centre--evaluation of the International Classification o...